MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

08 Nov 2024 Evaluate
The September 2024 quarter revenue stood at Rs. 1967.48 millions, up 18.06% as compared to Rs. 1666.44 millions during the corresponding quarter last year.A slim rise of 18.33% was recorded in the Net profit for the quarter ended September 2024 to Rs. 142.57  millions  From Rs. 120.48 millions.The company reported a good operating profit of 331.65 millions compared to 286.33 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1967.48 1666.44 18.06 3611.99 3019.83 19.61 7092.63 5220.51 35.86
Other Income 13.05 8.10 61.11 26.73 13.23 102.04 44.60 49.14 -9.24
PBIDT 331.65 286.33 15.83 679.98 558.03 21.85 1213.04 595.88 103.57
Interest 46.06 55.72 -17.34 92.73 118.95 -22.04 234.57 219.13 7.05
PBDT 285.59 230.61 23.84 587.25 439.08 33.75 978.47 376.75 159.71
Depreciation 86.20 79.00 9.11 170.02 155.91 9.05 315.16 321.25 -1.90
PBT 199.39 151.61 31.52 417.23 283.17 47.34 663.31 55.50 1095.15
TAX 56.82 31.13 82.52 111.38 69.87 59.41 169.07 14.65 1054.06
Deferred Tax 9.82 0.13 7453.85 11.38 4.87 133.68 17.79 14.69 21.10
PAT 142.57 120.48 18.33 305.85 213.30 43.39 494.24 40.85 1109.89
Equity 84.65 84.65 0.00 84.65 84.65 0.00 84.65 84.65 0.00
PBIDTM(%) 16.86 17.18 -1.89 18.83 18.48 1.88 17.10 11.41 49.84
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..